Delhi AIIMS is going to start a booster dose trial of Indian firm Bharat Biotech’s Intranasal Covid-19 vaccine from this week. This booster dose is for those who got vaccine shots of Covaxin or the Covishield atleast five months ago.
The objective of the trial — titled as ‘Phase 3, Randomized, Multi-Centric, Open-labeled Study to Evaluate Immunogenicity and Safety of BBV154 Booster Dose in Participants Previously Vaccinated with EUA Vaccines’ — is to comprehend the best mix of heterologous helping.
The purpose of this is to evaluate the safety of three vaccines as a booster dose in individuals previously vaccinated in india. The experts are really hopeful with this new initiative to stop properly the attack of the virus.